newsfilter
← Latest News
PR Newswire·

Invitae's PCM Assay for Minimal Residual Disease Receives its First Commercial Coverage

– Blue Shield of California has over 3 million covered members in CA – SAN FRANCISCO, March 6, 2023 /PRNewswire/ -- Invitae (NYSE:NVTA), a leading medical genetics company, today announced that its Personalized Cancer